Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series. | Khaled Mansour

Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series.

Citation:: Abdelhakim, M. A. S. E., T. A. Macky, K. A. G. Mansour, and H. A. Mortada, "Bevacizumab (Avastin) as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series.", Ophthalmic Research, vol. 45, issue DOI: 10.1159/000314721, pp. 23-30, 2011.